Bevatas 300mg Solution for Infusion
Bevatas 300mg Solution for Infusion is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
Bevatas 300mg Solution for Infusion
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Bevatas 300mg Solution for Infusion is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
Bevatas 300mg Solution for Infusion is an anticancer medication. It is used in the treatment of cancer of colon and rectum, non-small cell lung cancer, kidney cancer, brain tumor, ovarian and cervical cancer. It helps to prevent the growth of new blood vessels that feed tumors and stops tumors from growing.
Bevatas 300mg Solution for Infusion is an effective medicine, first-line option when used together with other cancer medicines. It is given as an infusion. That means you get it through a small needle in your vein or through a port, which is a device placed under your skin. The doctor will decide your dose and duration and will check you for signs of an infusion reaction such as high blood pressure and trouble breathing. You keep taking Bevatas 300mg Solution for Infusion as long as your disease is controlled and your side effects are manageable. Your doctor will determine whether you should stop taking it or not. You may be advised to check blood pressure and levels of protein in urine while you are taking this medication.
The most common side effects of this medicine include nosebleeds, headache, high blood pressure, rhinitis, protein in urine, change in taste, dry skin, bleeding, lacrimation disorder, back pain, and exfoliative dermatitis. Inform your doctor that you are taking this medication before undergoing any surgical procedure, as the drug has ability to lower the ability of wound healing. Other than this, it also enhances your risk of bleeding thus if you notice any unusual bleeding or bleeding consult with your doctor immediately.
Inform your doctor if you are pregnant, planning pregnancy or breastfeeding. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using.
03Uses
Cancer of colon and rectum
Non-small cell lung cancer
Ovarian cancer
Cervical cancer
Brain tumor
Kidney cancer
04How To Use
Your doctor or nurse will give you this medicine. Kindly do not self-administer.
05How It Works
Bevatas 300mg Solution for Infusion is a anti-angiogenic medication. It works by blocking a protein called vascular endothelial growth factor (VEGF). This stops the formation of blood vessels that bring oxygen and nutrients to cancerous cells.
06What If You Miss A Dose?
Q: What if you forget to take Bevatas Solution for Infusion?
A: If you miss a dose of Bevatas 300mg Solution for Infusion, please consult your doctor.
07Side Effects
Nosebleeds
Headache
High blood pressure
Inflammation of the nose
Protein in urine
Taste change
Dry skin
Hemorrhage
Increased lacrimation
Back pain
Exfoliative dermatitis
08Safety Information
Alcohol:CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Bevatas 300mg Solution for Infusion. Please consult your doctor.
Pregnancy:CONSULT YOUR DOCTOR
Bevatas 300mg Solution for Infusion may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding:CONSULT YOUR DOCTOR
Bevatas 300mg Solution for Infusion is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Driving:UNSAFE
Bevatas 300mg Solution for Infusion may cause side effects which could affect your ability to drive.Sleepiness and fainting have been reported with Bevatas 300mg Solution for Infusion and this may impair your ability to drive.
Kidney:SAFE IF PRESCRIBED
Bevatas 300mg Solution for Infusion is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Bevatas 300mg Solution for Infusion may not be needed in these patients. Please consult your doctor.
Liver:SAFE IF PRESCRIBED
Bevatas 300mg Solution for Infusion is probably safe to use in patients with liver disease. Limited data available suggests that dose adjustment of Bevatas 300mg Solution for Infusion may not be needed in these patients. Please consult your doctor.
09Drug Tips
Bevatas 300mg Solution for Infusion is an effective, first-line option when used together with other medicines for certain types of cancers such as colorectal, lung, cervical, and kidney cancers.
Bevatas 300mg Solution for Infusion is given as an infusion. Your doctor or nurse will monitor you for signs of an infusion reaction such as high blood pressure and trouble breathing.
It can lower your wound healing ability. Inform your doctor that you are taking this medication before undergoing any surgical procedure.
It can increase the risk of bleeding. Inform your doctor if you notice any unusual bleeding or bleeding that doesn’t stop easily.
Your doctor may regularly check your blood pressure and levels of protein in your urine while you are on Bevatas 300mg Solution for Infusion.
References
Sources and references
Avastin (Bevacizumab) [Product Information]. [Accessed 07 Oct. 2024] (online) Available from: View
Avastin (Bevacizumab) [Prescribing Information]. South San Francisco, CA: Genentech, Inc.; 2022. [Accessed 07 Oct. 2024] (online) Available from: View
Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1739-40.
Chu E, Sartorelli AC. Cancer Chemotherapy. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 955.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 142-43.
Bevacizumab. South San Francisco, California: Genentech, Inc.; 2004 [revised Sep. 2011]. [Accessed 26 Mar. 2019] (online) Available from: View
Drugs and Lactation Database (LactMed) [Internet]. Bethesda (MD): National Library of Medicine (US); 2006. Bevacizumab. [Updated 2019 Jul 20]. [Accessed 18 Feb. 2020] (online) Available from: View
